ENST00000376108.7:c.-178C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000376108.7(CLCN5):​c.-178C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 750,635 control chromosomes in the GnomAD database, including 1 homozygotes. There are 95 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00043 ( 1 hom. 90 hem. )

Consequence

CLCN5
ENST00000376108.7 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.47

Publications

0 publications found
Variant links:
Genes affected
CLCN5 (HGNC:2023): (chloride voltage-gated channel 5) This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
CLCN5 Gene-Disease associations (from GenCC):
  • Dent disease type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000215 (24/111850) while in subpopulation NFE AF = 0.000432 (23/53227). AF 95% confidence interval is 0.000295. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000376108.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN5
NM_001127898.4
MANE Select
c.164-2249C>T
intron
N/ANP_001121370.1P51795-2
CLCN5
NM_000084.5
c.-178C>T
5_prime_UTR
Exon 1 of 12NP_000075.1P51795-1
CLCN5
NM_001440756.1
c.176-2249C>T
intron
N/ANP_001427685.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN5
ENST00000376108.7
TSL:1
c.-178C>T
5_prime_UTR
Exon 1 of 12ENSP00000365276.3P51795-1
CLCN5
ENST00000376091.8
TSL:2 MANE Select
c.164-2249C>T
intron
N/AENSP00000365259.3P51795-2
CLCN5
ENST00000376088.7
TSL:2
c.164-2249C>T
intron
N/AENSP00000365256.3P51795-2

Frequencies

GnomAD3 genomes
AF:
0.000215
AC:
24
AN:
111850
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000955
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000432
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000434
AC:
277
AN:
638785
Hom.:
1
Cov.:
19
AF XY:
0.000473
AC XY:
90
AN XY:
190425
show subpopulations
African (AFR)
AF:
0.0000808
AC:
1
AN:
12380
American (AMR)
AF:
0.00
AC:
0
AN:
816
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3957
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3013
South Asian (SAS)
AF:
0.00
AC:
0
AN:
11964
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
263
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1101
European-Non Finnish (NFE)
AF:
0.000450
AC:
263
AN:
584181
Other (OTH)
AF:
0.000616
AC:
13
AN:
21110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000215
AC:
24
AN:
111850
Hom.:
0
Cov.:
23
AF XY:
0.000147
AC XY:
5
AN XY:
34028
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30773
American (AMR)
AF:
0.0000955
AC:
1
AN:
10474
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3586
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2658
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6061
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000432
AC:
23
AN:
53227
Other (OTH)
AF:
0.00
AC:
0
AN:
1502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000162

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Dent disease type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
19
DANN
Benign
0.92
PhyloP100
1.5
PromoterAI
-0.089
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781792158; hg19: chrX-49832285; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.